Nathan Vingerhoets’ Post

How do we protect Public Health in a Changing World 🌍? Our insightful interview with Hugues Malonne, CEO of the FAMHP - Federal Agency for Medicines and Health Products (FAMHP) in Belgium, depicts the Agency’s priorities in answering this question: 🔍 As Belgium takes the helm of the EU presidency in 2024, the focus is sharply on advancing the new EU pharmaceutical package proposal to secure timely and equitable access to safe and effective medicines for all; 🌐 Availability and the prevention of shortages will be a critical focus, notably with the launch of the Critical Medicines Alliance; 🤝 Partnerships, innovation, transparency and collaboration with patients and patient organisations will enable broader and faster patient access to innovative medicines. Discover the full interview here: https://pwc.to/3wwNaT0

How do we protect Public Health in a Changing World 🌍? Our insightful interview with Hugues Malonne, CEO of the FAMHP - Federal Agency for Medicines and Health Products (FAMHP) in Belgium, depicts the Agency’s priorities in answering this question: 🔍 As Belgium takes the helm of the EU presidency in 2024, the focus is sharply on advancing the new EU pharmaceutical package proposal to secure timely and equitable access to safe and effective medicines for all; 🌐 Availability and the prevention of shortages will be a critical focus, notably with the launch of the Critical Medicines Alliance; 🤝 Partnerships, innovation, transparency and collaboration with patients and patient organisations will enable broader and faster patient access to innovative medicines. Discover the full interview here: https://pwc.to/3wwNaT0

How do we protect Public Health in a Changing World 🌍? Our insightful interview with Hugues Malonne, CEO of the FAMHP - Federal Agency for Medicines and Health Products (FAMHP) in Belgium, depicts the Agency’s priorities in answering this question: 🔍 As Belgium takes the helm of the EU presidency in 2024, the focus is sharply on advancing the new EU pharmaceutical package proposal to secure timely and equitable access to safe and effective medicines for all; 🌐 Availability and the prevention of shortages will be a critical focus, notably with the launch of the Critical Medicines Alliance; 🤝 Partnerships, innovation, transparency and collaboration with patients and patient organisations will enable broader and faster patient access to innovative medicines. Discover the full interview here: https://pwc.to/3wwNaT0

How do we protect Public Health in a Changing World 🌍? Our insightful interview with Hugues Malonne, CEO of the FAMHP - Federal Agency for Medicines and Health Products (FAMHP) in Belgium, depicts the Agency’s priorities in answering this question: 🔍 As Belgium takes the helm of the EU presidency in 2024, the focus is sharply on advancing the new EU pharmaceutical package proposal to secure timely and equitable access to safe and effective medicines for all; 🌐 Availability and the prevention of shortages will be a critical focus, notably with the launch of the Critical Medicines Alliance; 🤝 Partnerships, innovation, transparency and collaboration with patients and patient organisations will enable broader and faster patient access to innovative medicines. Discover the full interview here: https://pwc.to/3wwNaT0

How do we protect Public Health in a Changing World 🌍? Our insightful interview with Hugues Malonne, CEO of the FAMHP - Federal Agency for Medicines and Health Products (FAMHP) in Belgium, depicts the Agency’s priorities in answering this question: 🔍 As Belgium takes the helm of the EU presidency in 2024, the focus is sharply on advancing the new EU pharmaceutical package proposal to secure timely and equitable access to safe and effective medicines for all; 🌐 Availability and the prevention of shortages will be a critical focus, notably with the launch of the Critical Medicines Alliance; 🤝 Partnerships, innovation, transparency and collaboration with patients and patient organisations will enable broader and faster patient access to innovative medicines. Discover the full interview here: https://pwc.to/3wwNaT0

How do we protect Public Health in a Changing World 🌍? Our insightful interview with Hugues Malonne, CEO of the FAMHP - Federal Agency for Medicines and Health Products (FAMHP) in Belgium, depicts the Agency’s priorities in answering this question: 🔍 As Belgium takes the helm of the EU presidency in 2024, the focus is sharply on advancing the new EU pharmaceutical package proposal to secure timely and equitable access to safe and effective medicines for all; 🌐 Availability and the prevention of shortages will be a critical focus, notably with the launch of the Critical Medicines Alliance; 🤝 Partnerships, innovation, transparency and collaboration with patients and patient organisations will enable broader and faster patient access to innovative medicines. Discover the full interview here: https://pwc.to/3wwNaT0

How do we protect Public Health in a Changing World 🌍? Our insightful interview with Hugues Malonne, CEO of the FAMHP - Federal Agency for Medicines and Health Products (FAMHP) in Belgium, depicts the Agency’s priorities in answering this question: 🔍 As Belgium takes the helm of the EU presidency in 2024, the focus is sharply on advancing the new EU pharmaceutical package proposal to secure timely and equitable access to safe and effective medicines for all; 🌐 Availability and the prevention of shortages will be a critical focus, notably with the launch of the Critical Medicines Alliance; 🤝 Partnerships, innovation, transparency and collaboration with patients and patient organisations will enable broader and faster patient access to innovative medicines. Discover the full interview here: https://pwc.to/3wwNaT0

How do we protect Public Health in a Changing World 🌍? Our insightful interview with Hugues Malonne, CEO of the FAMHP - Federal Agency for Medicines and Health Products (FAMHP) in Belgium, depicts the Agency’s priorities in answering this question: 🔍 As Belgium takes the helm of the EU presidency in 2024, the focus is sharply on advancing the new EU pharmaceutical package proposal to secure timely and equitable access to safe and effective medicines for all; 🌐 Availability and the prevention of shortages will be a critical focus, notably with the launch of the Critical Medicines Alliance; 🤝 Partnerships, innovation, transparency and collaboration with patients and patient organisations will enable broader and faster patient access to innovative medicines. Discover the full interview here: https://pwc.to/3wwNaT0

How do we protect Public Health in a Changing World 🌍? Our insightful interview with Hugues Malonne, CEO of the FAMHP - Federal Agency for Medicines and Health Products (FAMHP) in Belgium, depicts the Agency’s priorities in answering this question: 🔍 As Belgium takes the helm of the EU presidency in 2024, the focus is sharply on advancing the new EU pharmaceutical package proposal to secure timely and equitable access to safe and effective medicines for all; 🌐 Availability and the prevention of shortages will be a critical focus, notably with the launch of the Critical Medicines Alliance; 🤝 Partnerships, innovation, transparency and collaboration with patients and patient organisations will enable broader and faster patient access to innovative medicines. Discover the full interview here: https://pwc.to/3wwNaT0

How do we protect Public Health in a Changing World 🌍? Our insightful interview with Hugues Malonne, CEO of the FAMHP - Federal Agency for Medicines and Health Products (FAMHP) in Belgium, depicts the Agency’s priorities in answering this question: 🔍 As Belgium takes the helm of the EU presidency in 2024, the focus is sharply on advancing the new EU pharmaceutical package proposal to secure timely and equitable access to safe and effective medicines for all; 🌐 Availability and the prevention of shortages will be a critical focus, notably with the launch of the Critical Medicines Alliance; 🤝 Partnerships, innovation, transparency and collaboration with patients and patient organisations will enable broader and faster patient access to innovative medicines. Discover the full interview here: https://pwc.to/3wwNaT0